These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 33348039)

  • 21. A randomized trial of atropine regimens for treatment of moderate amblyopia in children.
    Repka MX; Cotter SA; Beck RW; Kraker RT; Birch EE; Everett DF; Hertle RW; Holmes JM; Quinn GE; Sala NA; Scheiman MM; Stager DR; Wallace DK;
    Ophthalmology; 2004 Nov; 111(11):2076-85. PubMed ID: 15522375
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of amblyopia therapy on ocular alignment.
    Repka MX; Holmes JM; Melia BM; Beck RW; Gearinger MD; Tamkins SM; Wheeler DT;
    J AAPOS; 2005 Dec; 9(6):542-5. PubMed ID: 16414520
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative efficacy of penalization methods in moderate to mild amblyopia.
    Tejedor J; Ogallar C
    Am J Ophthalmol; 2008 Mar; 145(3):562-9. PubMed ID: 18207121
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amblyopia in children aged 7 to 17 years.
    Phillips CI
    Arch Ophthalmol; 2006 Nov; 124(11):1668; author reply 1668-9. PubMed ID: 17102030
    [No Abstract]   [Full Text] [Related]  

  • 25. Combined optical and atropine treatment of children with residual amblyopia after atropine penalization.
    Simon JW; Sood AB; Mali JO
    J Pediatr Ophthalmol Strabismus; 2013 Feb; 50 Online():e6-7. PubMed ID: 23429575
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Contradictions in the amblyopia treatment studies.
    Lempert P
    Arch Ophthalmol; 2006 Feb; 124(2):285; author reply 285-7. PubMed ID: 16476906
    [No Abstract]   [Full Text] [Related]  

  • 27. Recent advances in the treatment of amblyopia.
    Quinn GE; Beck RW; Holmes JM; Repka MX;
    Pediatrics; 2004 Jun; 113(6):1800-2. PubMed ID: 15173508
    [No Abstract]   [Full Text] [Related]  

  • 28. Combined optical and atropine penalization for the treatment of strabismic and anisometropic amblyopia.
    Kaye SB; Chen SI; Price G; Kaye LC; Noonan C; Tripathi A; Ashwin P; Cota N; Clark D; Butcher J
    J AAPOS; 2002 Oct; 6(5):289-93. PubMed ID: 12381987
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification and treatment of amblyopia.
    Bradfield YS
    Am Fam Physician; 2013 Mar; 87(5):348-52. PubMed ID: 23547551
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of 4-Month Intermittent Atropine Penalization in Amblyopic Children for Whom Patch Therapy Had Failed.
    Seol BR; Yu YS; Kim SJ
    J Pediatr Ophthalmol Strabismus; 2017 Nov; 54(6):375-380. PubMed ID: 28678304
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The lazy eye - contemporary strategies of amblyopia treatment].
    Sturm V
    Praxis (Bern 1994); 2011 Feb; 100(4):229-35. PubMed ID: 21328237
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The treatment of amblyopia: current practice and emerging trends.
    Papageorgiou E; Asproudis I; Maconachie G; Tsironi EE; Gottlob I
    Graefes Arch Clin Exp Ophthalmol; 2019 Jun; 257(6):1061-1078. PubMed ID: 30706134
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The treatment of amblyopia.
    Holmes JM; Repka MX; Kraker RT; Clarke MP
    Strabismus; 2006 Mar; 14(1):37-42. PubMed ID: 16513568
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Visual outcome and success of amblyopia treatment in unilateral small posterior lens opacities and lenticonus initially treated nonsurgically.
    Travi GM; Schnall BM; Lehman SS; Kelly CJ; Hug D; Hirakata VN; Calhoun JH
    J AAPOS; 2005 Oct; 9(5):449-54. PubMed ID: 16213394
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Atropine vs. patching for the treatment of moderate amblyopia in children.
    Kushner BJ
    Arch Ophthalmol; 2002 Mar; 120(3):387-8. PubMed ID: 11879145
    [No Abstract]   [Full Text] [Related]  

  • 36. Development and evaluation of a patching treatment questionnaire for Chinese amblyopic children.
    Xu J; Lu Q; Huang Y; Chen Y; Chen J; Yu X
    Chin Med J (Engl); 2014; 127(7):1261-5. PubMed ID: 24709177
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk factors for treatment failure of anisometropic amblyopia.
    Hussein MA; Coats DK; Muthialu A; Cohen E; Paysse EA
    J AAPOS; 2004 Oct; 8(5):429-34. PubMed ID: 15492734
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of media press coverage on parental preferences in amblyopia treatment.
    Golden RP; Olitsky SE
    J AAPOS; 2005 Jun; 9(3):212-5. PubMed ID: 15956939
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amblyopia can be treated without occlusion or atropine.
    Isenberg SJ
    Ophthalmology; 2006 Jun; 113(6):893. PubMed ID: 16751031
    [No Abstract]   [Full Text] [Related]  

  • 40. Pharmacological plus optical penalization treatment for amblyopia: results of a randomized trial.
    Pediatric Eye Disease Investigator Group
    Arch Ophthalmol; 2009 Jan; 127(1):22-30. PubMed ID: 19139333
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.